Varian's "smart" imaging tool:
This article was originally published in Clinica
Executive Summary
Varian Medical Systems has received FDA 510(k) clearance for its Smart Segmentation technology, a radiotherapy treatment planning tool. It is designed to enable clinicians to reduce the amount of time needed to plan treatments including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), brachytherapy, and proton therapy. The Palo Alto, California firm claims that the new Smart Segmentation feature, which has been added to Varian's Eclipse treatment planning product, is the world's first fully automatic tool that uses intelligent software to identify organs and other structures within diagnostic images of the thorax and male pelvis. The Smart Segmentation tool can automatically identify all of the structures of interest in less than 45 seconds. Previously, structures requiring radiotherapy or protection from radiotherapy had to be identified manually.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.